Request for Covid-19 Impact Assessment of this Report

ICT & Media

Global Non-Invasive Prenatal Screening (NIPS) Market Growth (Status and Outlook) 2022-2028

  • LP 4939374
  • 101 Pages
  • March 2022
  • ICT & Media
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Non-Invasive Prenatal Screening (NIPS) will have significant change from previous year. According to our (LP Information) latest study, the global Non-Invasive Prenatal Screening (NIPS) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-Invasive Prenatal Screening (NIPS) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Non-Invasive Prenatal Screening (NIPS) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Non-Invasive Prenatal Screening (NIPS) market, reaching US$ million by the year 2028. As for the Europe Non-Invasive Prenatal Screening (NIPS) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Non-Invasive Prenatal Screening (NIPS) players cover Myriad Genetics, Illumina, Progenity, and Natera, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal Screening (NIPS) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Trisomy 21

Trisomy 18

Trisomy 13

Sex Chromosome Aneuploidies

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Clinical Laboratories

Hospital

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Myriad Genetics

Illumina

Progenity

Natera

Yourgene Health

Roche Sequencing Solutions (RSS)

Eurofins LifeCodexx GmbH

Labcorp

PerkinElmer

Harmony

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2028

2.1.2 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Type

2.2.1 Trisomy 21

2.2.2 Trisomy 18

2.2.3 Trisomy 13

2.2.4 Sex Chromosome Aneuploidies

2.2.5 Others

2.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Type

2.3.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

2.4 Non-Invasive Prenatal Screening (NIPS) Segment by Application

2.4.1 Clinical Laboratories

2.4.2 Hospital

2.5 Non-Invasive Prenatal Screening (NIPS) Market Size by Application

2.5.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

3 Non-Invasive Prenatal Screening (NIPS) Market Size by Player

3.1 Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Players

3.1.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022)

3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Players (2020-2022)

3.2 Global Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-Invasive Prenatal Screening (NIPS) by Regions

4.1 Non-Invasive Prenatal Screening (NIPS) Market Size by Regions (2017-2022)

4.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)

4.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)

4.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022)

5.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)

5.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022)

6.2 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)

6.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-Invasive Prenatal Screening (NIPS) by Country (2017-2022)

7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)

7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) by Region (2017-2022)

8.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)

10.1.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)

10.1.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast

10.1.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast

10.1.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast

10.1.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast

10.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)

10.2.1 United States Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.2.2 Canada Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.2.3 Mexico Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.2.4 Brazil Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)

10.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3.2 Japan Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3.3 Korea Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3.4 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3.5 India Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.3.6 Australia Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)

10.4.1 Germany Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.4.2 France Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.4.3 UK Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.4.4 Italy Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.4.5 Russia Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)

10.5.1 Egypt Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.5.2 South Africa Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.5.3 Israel Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.5.4 Turkey Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.5.5 GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Forecast

10.6 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Type (2023-2028)

10.7 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Information

11.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered

11.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Myriad Genetics Main Business Overview

11.1.5 Myriad Genetics Latest Developments

11.2 Illumina

11.2.1 Illumina Company Information

11.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered

11.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Illumina Main Business Overview

11.2.5 Illumina Latest Developments

11.3 Progenity

11.3.1 Progenity Company Information

11.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered

11.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Progenity Main Business Overview

11.3.5 Progenity Latest Developments

11.4 Natera

11.4.1 Natera Company Information

11.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Offered

11.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Natera Main Business Overview

11.4.5 Natera Latest Developments

11.5 Yourgene Health

11.5.1 Yourgene Health Company Information

11.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered

11.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Yourgene Health Main Business Overview

11.5.5 Yourgene Health Latest Developments

11.6 Roche Sequencing Solutions (RSS)

11.6.1 Roche Sequencing Solutions (RSS) Company Information

11.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered

11.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Roche Sequencing Solutions (RSS) Main Business Overview

11.6.5 Roche Sequencing Solutions (RSS) Latest Developments

11.7 Eurofins LifeCodexx GmbH

11.7.1 Eurofins LifeCodexx GmbH Company Information

11.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered

11.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Eurofins LifeCodexx GmbH Main Business Overview

11.7.5 Eurofins LifeCodexx GmbH Latest Developments

11.8 Labcorp

11.8.1 Labcorp Company Information

11.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered

11.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Labcorp Main Business Overview

11.8.5 Labcorp Latest Developments

11.9 PerkinElmer

11.9.1 PerkinElmer Company Information

11.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered

11.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 PerkinElmer Main Business Overview

11.9.5 PerkinElmer Latest Developments

11.10 Harmony

11.10.1 Harmony Company Information

11.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered

11.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Harmony Main Business Overview

11.10.5 Harmony Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Trisomy 21

Table 3. Major Players of Trisomy 18

Table 4. Major Players of Trisomy 13

Table 5. Major Players of Sex Chromosome Aneuploidies

Table 6. Major Players of Others

Table 7. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

Table 10. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

Table 13. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2020-2022)

Table 15. Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered

Table 16. Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)

Table 21. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)

Table 23. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

Table 25. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

Table 27. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)

Table 29. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

Table 31. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

Table 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)

Table 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

Table 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Non-Invasive Prenatal Screening (NIPS)

Table 46. Key Market Challenges & Risks of Non-Invasive Prenatal Screening (NIPS)

Table 47. Key Industry Trends of Non-Invasive Prenatal Screening (NIPS)

Table 48. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Application (2023-2028)

Table 54. Myriad Genetics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 55. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 56. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Myriad Genetics Main Business

Table 58. Myriad Genetics Latest Developments

Table 59. Illumina Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 60. Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 61. Illumina Main Business

Table 62. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Illumina Latest Developments

Table 64. Progenity Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 65. Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 66. Progenity Main Business

Table 67. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Progenity Latest Developments

Table 69. Natera Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 70. Natera Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 71. Natera Main Business

Table 72. Natera Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Natera Latest Developments

Table 74. Yourgene Health Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 75. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 76. Yourgene Health Main Business

Table 77. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Yourgene Health Latest Developments

Table 79. Roche Sequencing Solutions (RSS) Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 80. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 81. Roche Sequencing Solutions (RSS) Main Business

Table 82. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Roche Sequencing Solutions (RSS) Latest Developments

Table 84. Eurofins LifeCodexx GmbH Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 85. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 86. Eurofins LifeCodexx GmbH Main Business

Table 87. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Eurofins LifeCodexx GmbH Latest Developments

Table 89. Labcorp Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 90. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 91. Labcorp Main Business

Table 92. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Labcorp Latest Developments

Table 94. PerkinElmer Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 95. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 96. PerkinElmer Main Business

Table 97. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. PerkinElmer Latest Developments

Table 99. Harmony Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors

Table 100. Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered

Table 101. Harmony Main Business

Table 102. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Harmony Latest Developments

List of Figures

Figure 1. Non-Invasive Prenatal Screening (NIPS) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021

Figure 7. Non-Invasive Prenatal Screening (NIPS) in Clinical Laboratories

Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Market: Clinical Laboratories (2017-2022) & ($ Millions)

Figure 9. Non-Invasive Prenatal Screening (NIPS) in Hospital

Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021

Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player in 2021

Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)

Figure 15. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)

Figure 16. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)

Figure 18. Americas Non-Invasive Prenatal Screening (NIPS) Value Market Share by Country in 2021

Figure 19. Americas Non-Invasive Prenatal Screening (NIPS) Consumption Market Share by Type in 2021

Figure 20. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021

Figure 21. United States Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021

Figure 26. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021

Figure 27. China Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2021

Figure 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021

Figure 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021

Figure 36. Germany Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021

Figure 44. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 50. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 51. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 53. United States Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 54. Canada Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 57. China Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 58. Japan Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 59. Korea Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 61. India Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 62. Australia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 63. Germany Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 64. France Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 65. UK Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 66. Italy Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 67. Russia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 68. Spain Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 71. Israel Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Netbook Market in India 2011

The netbook sales in India have been growing strongly with major demand from the home segment. Personal computer market is expected to grow as the economy is recovering from the recession. The newest addition to this consumer product group is notebooks and netbooks. However, it has been seen that there is no clear demarcation between inexpensive notebook and netbook as an upgraded version of a net...

  • Publish Date: January 18, 2011
  • $950
Online Movie Rental Market in India 2011

The Online Movie Rental market in India is at a nascent stage. The market is estimated at INR 601 mn in 2008 and shows huge potential due to a large untapped consumer base. The changing perceptions of people towards entertainment along with a rise in their disposable income and internet usage have driven the market. The report begins with a market overview section that provides an insight into t...

  • Publish Date: March 7, 2011
  • $950
Local Search Market in India 2011

Local search market in India is a common platform for advertising used by business entities. It has an offline and an online category. Local search space provides a platform to the small and medium scale enterprises to advertise with regards to their products and services through local search engines and print directories such as yellow pages. The report begins with the market overview section wh...

  • Publish Date: June 27, 2011
  • $950